No Detail Found!

Antithrombin Iii Level in Patients of ?-thalassemia: a Cross-sectional Study.

Author(s)
Ammar Bin Saad Department of Pathology, Abbottabad International Medical College, Abbottabad, KPK, Pakistan
Javed Iqbal Khan Department of surgery, Abbottabad International Medical College, Abbottabad, KPK, Pakistan
Tahir Angez Khan Medicine, Abbottabad International Medical College, Abbottabad, Pakistan
Muhammad Basharat Khan Department of Pathology, Abbottabad International Medical College, Abbottabad, KPK, Pakistan
Nadia Altaf North West School of Medicine, Peshawar, Pakistan
Abstract
Background: Thalassemia is a genetic disorder associated with reduced production rate of either a single or more globin chains in the haemoglobin. Thalassemia is divided into two main types, alpha (a) thalassemia and beta (ß) thalassemia. The aim of this study was to determine antithrombin III level in diagnosed patients of beta thalassemia major. Methods: This cross-sectional study was conducted at Sheikh Zayed Hospital Lahore from Jan 2014 to Jan 2015. The sample size was 100 including 50 healthy controls and 50 patients with ß thalassemia major. Antithrombin III assay was done with Chromogenic determination of Antithrombin (AT) on an auto analyzer. Results: Mean age splenectomized group was 9.1±2.2 years and that for non-splenectomized and control group was 6.5±2.9. The mean antithrombin III level for the splenectomized group was 66.0±8.9% and that for non-splenectomized and control group was 78.6±9.6 and 91.9±4.7 respectively. The overall mean antithrombin III level for cases was 75.8±10.7. The differences for antithrombin III level were significant (p<0.001). The splenectomized group also had significantly lower antithrombin III level as compared to the non-splenectomized group (p=0.001). Conclusion: Antithrombin III level is significantly affected in thalassemia. A considerable difference was observed in antithrombin III levels of splenectomized and non-splenectomized patients.
Publication Details
Page(s) 40-43
DOI DOI not available
Published Journal: Pakistan Journal of Physiology, Volume: 14, Issue: 4, Year: 2018

Request the full text from PASTIC

Keywords
Thalassemia, Splenectomized, Antithrombin, Normality
References
HofmannR,BenzEJ,ShattilSJ,FurieB,SilbersteinLE,McGlaveP,HeslopLEE, 2009.,Hematology: Basic Principies and Practice -
WeatherallDJ,CleggJB, 2001.Inherited haemoglobin disorders: an increasing global health problem,Bull World Health Organ 79 704 -12
TripodiA,CappelliniMD,ChantarangkulV,PadovanL,FasuloMR,MarconA, 2009.Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in plateletpoor plasma,Haematologica 94 1520 -7
YasmeenH,TomaS,KilleenN,HasnainS,ForoniL, 2016.The molecular characterization of Beta globin gene in thalassemia patients reveals rare and a novel mutations in Pakistani population,Eur J Med Genet 59 355 -62
DussiotM,MacielTT,FricotA,ChartierC,NegreO,VeigaJ, 2014.An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia,Nat Med 20 398 -407
CollenD,SchetzJ,de Cock , F,E , Verstraete,M., 1977.Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration,Eur J Clin Invest 7 27 -35
SirachainanN,ThongsadJ,PakakasamaS,HongengS,ChuansumritA,KadegasemP, 2012.Normalized coagulation markers and anticoagulation proteins in children with severe ß- thalassemia sease after stem cell transplantation,Thromb Res 129 765 -70
TurkB,BrieditisI,BockSC,OlsonST,BjörkI., 1997.The oligosaccharide side chain on Asn-135 of α-antithrombin, absent in β-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change,Biochem 36 6682 -91
YangX,AlexanderKP,ChenAY,RoeMT,RG , Rao,SV, 2005.The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative,J Am Coll Cardiol 46 1490 -5
BullerHR, 1989.Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate,Am J Med 87 44 -8S
InthornD,HoffmannJN,HartlWH,MühlbayerD,JochumM. Antithrombin, 1997.III supplementation in severe sepsis: beneficial effects on organ dysfunction,Shock 8 328 -34
Chang , W,MR , Lomas,DA , Carrell,RW, 1996.Probing serpin reactive-loop conformations by proteolytic cleavage,Biochem J 314 647 -53
LaneDA,KunzG,OldsRJ,TheinSL, 1996.Molecular genetics of antithrombin deficiency,Blood Rev 10 59 -74
MaherCA,OldsT,WilliamsMT,LaneAE, 2008.Self-reported quality of life in adolescents with cerebral palsy,Phys Occup Ther Pediatr 28 41 -57
SasG, 1984.Hereditary antithrombin III deficiency: biochemical aspects,Haematologia (Budap) 17 81 -6
HameedA,HussainA,FayyazT,TayyabM,AhmadJ, 2002.Chronic liver disease assessment of antithrombin III level,Professional Med J 9 100 -5
ShoaibM,ShamsiT,NazA, 2008.Arteriovenous thrombosis in chronic renal patients receiving renal replacement therapy,J Coll Physicians Surg Pak 18 418 -23
OldsRJ,LaneDA,ChowdhuryV,De StefanoV,LeoneG,TheinSL, 1993.Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia,Biochem 32 4216 -24
RahmaniMTH,TayyabM,TasneemT., 1999.Plasma antithrombin III levels in Pakistani women with pre-eclampsia,J Ayub Med Coll Abbottabad 11 20 -3
SheikhMA,MemonI,GhoriRA, 2010.Frequency of anemia in patients with systemic lupus erythromatosis at tertiary care hospital,J Pak Med Assoc 60 822 -5
EldorA,DurstR,Hy-AmE,GoldfarbA,GillisS,RachmilewitzEA, 1999.A chronic hypercoagulable state in patients with betathalassaemia major is already present in childhood,Br J Haematol 107 739 -46
YasharVBB,BarenholtzY,Hy-AmE,RachmilewitzEA,EldorA, 1993.Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes,Am J Hematol 44 63 -5
CappelliniMD,CoppolaR,RobbioloL,GraziadeiG,ValentiniM,AriensRAS, 1996.Procoagulant activity of erythrocytes in thalassemia intermedia,Blood 88 38a -
0

Citations

0

Downloads

75

Views